Dr. Byun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
560 First Ave
Energy Building - 2nd Fl
New York, NY 10016Phone+1 646-501-8900
Summary
- Dr. David Byun is a board-certified radiation oncologist in New York, NY. He received his medical degree from Weill Cornell Medicine, and completed his training at Memorial Sloan Kettering Cancer Center and NYU Grossman School of Medicine. He specializes in urologic cancer and is experienced in cardiac radiation, brachytherapy, general radiation oncology, urologic radiation oncology, and stereotactic body radiotherapy. He also speaks multiple languages, including Korean.
Education & Training
NYU Grossman School of MedicineResidency, Radiation Oncology, 2018 - 2022
Memorial Sloan Kettering Cancer CenterResidency, Transitional Year, 2017 - 2018
Weill Cornell MedicineClass of 2017, M.D.
Cornell UniversityB.S., 2007 - 2011
Certifications & Licensure
NY State Medical License 2021 - 2025- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Roentgen Resident/Fellow Research Award RSNA Research & education Foundation, 2022
- Personalized Radiation Therapy Research Grant Radiation Oncology Institute, 2019
Clinical Trials
- INTREPId (INTermediate Risk Erection PreservatIon Trial) Start of enrollment: 2020 Jun 01
- Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate Start of enrollment: 2020 Mar 31
Publications & Presentations
PubMed
- 77 citationsThe Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for ManagementMonica Girotra, Aaron R. Hansen, Azeez Farooki, David J. Byun, Le Min
JNCI Cancer Spectrum. 2018-07-01 - 437 citationsCancer immunotherapy - immune checkpoint blockade and associated endocrinopathies.David J. Byun, Jedd D. Wolchok, Lynne Rosenberg, Monica Girotra
Nature Reviews. Endocrinology. 2017-04-01 - 25 citationsImmune Checkpoint Inhibitor-Associated Diabetes: A Single-Institution Experience.David J. Byun, Rebecca Braunstein, Jessica Flynn, Junting Zheng, Robert A. Lefkowitz
Diabetes Care. 2020-10-13
Press Mentions
The Risk of Second Primary Cancer After Prostate RadiotherapyAugust 3rd, 2022- Too Often, Women Aren't Told of Sexual Side Effects of Cancer TreatmentsOctober 26th, 2022
Long-term ADT Added to RT Improves Outcomes in Prostate CancerNovember 17th, 2022
Grant Support
- Collaborative Translational Pilot Project GrantNYU Clinical and Translational Science Institute2021–2022
- ROI Personalized Radiation Therapy Research GrantRadiation Oncology Institute2019–2022
- Luther Brady Educational Research GrantAmerican College of Radiation Oncology2019–2020
Professional Memberships
- Member
- Member
- American Brachytherapy Society - ABSMember
- Radiological Society of North America - RSNAMember
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
